Equity · Healthcare
AVNS
NYSEAvanos Medical (AVNS)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.
- Market cap
- 1.2B USD
- Revenue, year to Dec 2025
- 701.2M USD
- EPS, diluted, year to Dec 2025
- −1.57 USD
- 52-week range
- 9.90 USD – 25.07 USD
- Avg volume
- 215.3K
as of Jul 24, 2026
Have Avanos Medical (AVNS) insiders bought or sold shares recently?
AVNS's newest Form 4 filing is dated 27 July 2026: none in the last 90 days.
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 18 Nov 2025 | Holbrook KerrSVP, Chief Commercial Officer | Sell | 15,000 | 165K USD |
24 other filings: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 27 Jul 2026 | BLACKFORD GARYDirector | Other | 119,590 | 3.0M USD |
| 27 Jul 2026 | Egbuonu-Davis LisaDirector | Other | 13,811 | 345K USD |
| 27 Jul 2026 | Franchini Indrani LallDirector | Other | 4,817 | 120K USD |
| 27 Jul 2026 | OLEARY PATRICK JDirector | Other | 54,640 | 1.4M USD |
| 27 Jul 2026 | Shimer Julie AnnDirector | Other | 50,090 | 1.3M USD |
| 27 Jul 2026 | Pacitti DavidChief Executive Officer | Other | 766,924 | 19.2M USD |
| 27 Jul 2026 | Pacitti DavidChief Executive Officer | Award | 444,730 | |
| 27 Jul 2026 | Galovan Scott MichaelSVP, Chief Financial Officer | Other | 231,717 | 5.8M USD |
| 27 Jul 2026 | Galovan Scott MichaelSVP, Chief Financial Officer | Award | 96,121 | |
| 27 Jul 2026 | Delgado SigfridoSVP, Operations | Other | 110,627 | 2.8M USD |
| 27 Jul 2026 | Delgado SigfridoSVP, Operations | Award | 54,886 | |
| 22 Apr 2026 | Delgado SigfridoSVP, Operations | Tax withheld | 4,264 | 105K USD |
Showing the 12 most recent of 24 compensation filings in this window. The figures above count all of them.
Which funds hold Avanos Medical (AVNS)?
9 of the 45 institutional funds we track reported a Avanos Medical position for the quarter ended 30 Jun 2026 — a combined 85.0M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Millennium Management | Added | 1,524,553 | 37.9M USD | +10,926.7% |
| Balyasny Asset Management | New position | 739,829 | 18.4M USD | |
| Marshall Wace | New position | 354,231 | 8.8M USD | |
| D. E. Shaw & Co. | Trimmed | 280,729 | 7.0M USD | −58.2% |
| Renaissance Technologies | New position | 256,100 | 6.4M USD | |
| AQR Capital Management | Trimmed | 111,562 | 2.8M USD | −83.9% |
| Tudor Investment Corp | New position | 80,000 | 2.0M USD | |
| Two Sigma Investments | Trimmed | 48,288 | 1.2M USD | −45.8% |
| GAMCO Investors | New position | 20,000 | 498K USD | |
| Citadel Advisors | Exited |
What has been filed or recorded for Avanos Medical (AVNS)?
The filings we hold for Avanos Medical, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 31 Mar 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 0.11 USD | Revenue $182M |
| 31 Mar 2026 | Financials | Total assets | 1.1B USD | at period end |
| 31 Mar 2026 | Financials | Total equity | 782.1M USD | at period end |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −1.57 USD | Revenue $701M |
| 31 Dec 2025 | Financials | Revenue | 701.2M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −72.9M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −1.57 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.03 USD | Revenue $178M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −1.66 USD | Revenue $175M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 0.14 USD | Revenue $168M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −8.53 USD | Revenue $688M |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS 0.09 USD | Revenue $170M |
| 30 Jun 2024 | Quarterly earnings | Q2 2024 reported | EPS 0.04 USD | Revenue $172M |
What do people ask about Avanos Medical (AVNS)?
What is Avanos Medical’s market cap?1.2B
Avanos Medical is worth 1.2B USD by market value as of 24 Jul 2026, which is the share price times the shares on issue from its SEC filings.
What is Avanos Medical’s revenue?701.2M
Avanos Medical reported revenue of 701.2M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Avanos Medical insiders bought or sold shares recently?
No Avanos Medical insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 27 Jul 2026 (SEC Form 4). See Insiders
Which funds own Avanos Medical?9 of 45
9 of the 45 funds we track reported a Avanos Medical position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Millennium Management, Balyasny Asset Management and Marshall Wace. See Funds
When did Avanos Medical last report earnings?0.11
Avanos Medical last reported earnings on 31 Mar 2026 for Q1 2026, with EPS of 0.11 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SEC EDGARXBRL company facts, latest period ended 31 Mar 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings